Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cornberg

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Journal of Viral Hepatitis|March 29, 2014
Development and evaluation of a baseline-event-anticipation score for hepatitis deltaB Calle Serrano, A Großhennig, M Homs, et al.
Vaccine|June 28, 2008
Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073P Fytili, G N Dalekos, V Schlaphoff, et al.
Zeitschrift Fur Gastroenterologie|February 3, 2023
[Strategietreffen: Virushepatitis in Deutschland eliminieren]T L Tergast, U Protzer, S Zeuzem, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2018
A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis BH L Y Chan, D Messinger, G V Papatheodoridis, et al.
Vaccine|May 12, 2009
Hepatitis C virus-specific T cell responses against conserved regions in recovered patientsC S Klade, A Kubitschke, R E Stauber, et al.
Alimentary Pharmacology & Therapeutics|August 8, 2015
Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapiesK Deterding, C Höner Zu Siederdissen, K Port, et al.
Zeitschrift Fur Gastroenterologie|June 18, 2009
The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infectionK Deterding, J Wiegand, N Grüner, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2017
Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infectionM Cornberg, J Petersen, A Schober, et al.
Zeitschrift Fur Gastroenterologie|January 7, 2012
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]C Sarrazin, T Berg, M Cornberg, et al.
Zeitschrift Fur Gastroenterologie|February 4, 2010
Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximabM A Stange, O Tutarel, S Pischke, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Journal of Viral Hepatitis|March 29, 2014
Development and evaluation of a baseline-event-anticipation score for hepatitis deltaB Calle Serrano, A Großhennig, M Homs, et al.
Vaccine|June 28, 2008
Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073P Fytili, G N Dalekos, V Schlaphoff, et al.
Zeitschrift Fur Gastroenterologie|February 3, 2023
[Strategietreffen: Virushepatitis in Deutschland eliminieren]T L Tergast, U Protzer, S Zeuzem, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2018
A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis BH L Y Chan, D Messinger, G V Papatheodoridis, et al.
Vaccine|May 12, 2009
Hepatitis C virus-specific T cell responses against conserved regions in recovered patientsC S Klade, A Kubitschke, R E Stauber, et al.
Alimentary Pharmacology & Therapeutics|August 8, 2015
Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapiesK Deterding, C Höner Zu Siederdissen, K Port, et al.
Zeitschrift Fur Gastroenterologie|June 18, 2009
The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infectionK Deterding, J Wiegand, N Grüner, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2017
Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infectionM Cornberg, J Petersen, A Schober, et al.
Zeitschrift Fur Gastroenterologie|January 7, 2012
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]C Sarrazin, T Berg, M Cornberg, et al.
Zeitschrift Fur Gastroenterologie|February 4, 2010
Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximabM A Stange, O Tutarel, S Pischke, et al.
Pageof 7